Abo-zeid Y, Williams GR (2020) The potential anti-infective applications of metal oxide nanoparticles: a systematic review. Wiley Interdiscip Rev Nanomed Nanobiotechnol 12(2):1–36. https://doi.org/10.1002/wnan.1592
Ahmadi E, Dehghannejad N, Hashemikia S, Ghasemnejad M, Tabebordbar H (2014) Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery. Drug Deliv 21(3):164–172. https://doi.org/10.3109/10717544.2013.838715
Araújo LAD, Addor F, Campos PMBGM (2016) Use of silicon for skin and hair care: an approach of chemical forms available and efficacy. An Bras Dermatol 91:0331–0335
Arciola CR, Campoccia D, Montanaro L (2018) Implant infections: adhesion, biofilm formation and immune evasion. Nat Rev Microbiol 16:397–409
Arias LS, Pessan JP, Vieira APM, Tmt DL, Delbem ACB, Monteiro DR (2018) Iron oxide nanoparticles for biomedical applications: a perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics. 7:2. https://doi.org/10.3390/antibiotics7020046
Bai Y-M, Mao J, Xiong LD et al (2019) Bimodal antibacterial system based on quaternary ammonium silane-coupled core-shell hollow mesoporous silica. Acta Biomater 85:229–240. https://doi.org/10.1016/j.actbio.2018.12.037
Bai Y, An N, Chen D, Liu YZ, Liu CP, Yao H, Wang C, Song X, Tian W (2020) Facile construction of shape-regulated βcyclodextrin-based supramolecular self-assemblies for drug delivery. Carbohydr Polym 231:115714
Balaure PC, Boarca B, Popescu RC et al (2017) Bioactive mesoporous silica nanostructures with anti-microbial and anti-biofilm properties. Int J Pharm 531(1):35–46. https://doi.org/10.1016/j.ijpharm.2017.08.062
Barani M, Paknia F, Roostaee M, Kavyani B, Kalantar-Neyestanaki D, Ajalli N, Amirbeigi A (2023) Niosome as an effective nanoscale solution for the treatment of microbial infections. Biomed Res Int 2023:9933283, 18 pages. https://doi.org/10.1155/2023/9933283
Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, Bagheri KP (2018) Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter Baumannii. Eur J Clin Microbiol Infect Dis 37:443–454
Benezra M, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, Burns A, ... Bradbury MS (2011) Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Investig 121(7):2768–2780
Bernardos A, Piacenza E, Sancenón F, Hamidi M, Maleki A, Turner RJ, Martínez-Máñez R (2019) Mesoporous silica-based materials with bactericidal properties. Small. 15:1900669. https://doi.org/10.1002/smll.201900669
Bharti C, Nagaich U, Pal AK, Gulati N (2015) Mesoporous silica nanoparticles in target drug delivery system: A review. Int J Pharm Investig 5(3):124–33. https://doi.org/10.4103/2230-973X.160844
Braun K, Pochert A, Lindén M et al (2016) Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides. J Colloid Interface Sci 475:161–170. https://doi.org/10.1016/j.jcis.2016.05.002
Budimir M, Jijie R, Ye R, Barras A, Melinte S, Silhanek A, Markovic Z, Szunerits S, Boukherroub R (2019) Efficient capture and photothermal ablation of planktonic bacteria and biofilms using reduced graphene oxide−polyethyleneimine flexible nanoheaters. J Mater Chem B 7:2771–2781
Bukara K, Schueller L, Rosier J, Martens MA, Daems T, Verheyden L, Eelen S, Van Speybroeck M, Libanati C, Martens JA, Van Den Mooter G, Fre´rart F, Jolling K, De Gieter M, Bugarski B, Kiekens F (2016) Eur J Pharm Biopharm 108:220–225
Burns AA, Vider J, Ow H, Herz E, Penate-Medina O, Baumgart M, ... Bradbury M (2009) Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9(1):442–448
Carvalho GC, Sábio RM, de Cássia Ribeiro T, Monteiro AS, Pereira DV, Ribeiro SJL, Chorilli M (2020) Highlights in mesoporous silica nanoparticles as a multifunctional controlled drug delivery nanoplatform for infectious diseases treatment. Pharm Res 37:191. https://doi.org/10.1007/s11095-020-02917-6
Castillo RR, Vallet-Regí M (2021) Recent advances toward the use of mesoporous silica nanoparticles for the treatment of bacterial infections. Int J Nanomed 16:4409–4430. https://doi.org/10.2147/IJN.S273064
Chang Z-M, Wang Z, MengLu M et al (2017) Janus silver mesoporous silica nanobullets with synergistic antibacterial functions. Colloids Surf B Biointerfaces 157:199–206. https://doi.org/10.1016/j.colsurfb.2017.05.079
Chen Y, Chen H, Shi J (2013) In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv Mater 25(23):3144–3176
Chen X, Liu Y, Lin A et al (2018) Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems. Biomater Sci 6(7):1923–1935. https://doi.org/10.1039/c8bm00262b
Chen W, Glackin CA, Horwitz MA, Zink JI (2019) Nanomachines and other caps on mesoporous silica nanoparticles for drug delivery. Acc Chem Res 52:1531–1542
Chen X, Xu C, He H (2019) Electrospinning of silica nanoparticles-entrapped nanofibers for sustained gentamicin release. Biochem Biophys Res Commun 516(4):1085–1089. https://doi.org/10.1016/j.bbrc.2019.06.163
Chen W, Cheng CA, Zink JI (2019) Spatial, temporal, and dose control of drug delivery using noninvasive magnetic stimulation. ACS Nano 13:1292–1308
Chen F, Nayak TR, Goel S, Valdovinos HF, Hong H, Theuer CP, … Cai W (2014) In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)‐conjugated, dual‐labeled mesoporous silica nanoparticles. Mol Pharm 11(11):4007–4014. https://doi.org/10.1021/mp500306k
Chen L, Liu J, Zhang Y, Zhang G, Kang Y, Chen A, … Shao L (2018) The toxicity of silica nanoparticles to the immune system. Nanomedicine (London, England) 13(15):1939–1962. https://doi.org/10.2217/nnm-2018-0076
Chen H, Shen Z, Wu P et al (2020) Long effective tea tree oil/mesoporous silica sustained release system decorated by polyethyleneimine with high antibacterial performance. J Dispers Sci Technol 42(10):1448–1459. https://doi.org/10.1080/01932691.2020.1772816
Cheng G, Zhang Z, Chen S, Bryers JD, Jiang S (2007) Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces. Biomaterials 28(29):4192–4199. https://doi.org/10.1016/j.biomaterials.2007.05.041
Cheng Y, Zhang Y, Deng W, Hu J (2020) Antibacterial and anticancer activities of asymmetric lollipop-like mesoporous silica nanoparticles loaded with curcumin and gentamicin sulfate. Colloids Surf B Biointerfaces 186:110744. https://doi.org/10.1016/j.colsurfb.2019.110744
Chircov C, Spoială A, Păun C, Crăciun L, Ficai D, Ficai A, ... Turculeƫ ȘC (2020) Mesoporous silica platforms with potential applications in release and adsorption of active agents. Molecules 25(17):3814
Choi J, Burns AA, Williams RM, Zhou Z, Flesken-Nikitin A, Zipfel WR, ... Nikitin AY (2007) Core-shell silica nanoparticles as fluorescent labels for nanomedicine. J Biomed Opt 12(6):064007
Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay Method. Cancer Res 70:440–446
Colilla M, Vallet-Regí M (2020) Targeted stimuli-responsive mesoporous silica nanoparticles for bacterial infection treatment. Int J Mol Sci 21:8605. https://doi.org/10.3390/ijms21228605
de Azevedo M, Oliveira LF, Teles da Silva LV et al (2020) Antioxidant and antimicrobial activity of red propolis embedded mesoporous silica nanoparticles. Drug Dev Ind Pharm 46(7):1199–1208. https://doi.org/10.1080/03639045.2020.1782423
Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Burns JL, Montelaro RC (2015) Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens. Antimicrob Agents Chemother 59:1329–1333
Dinali R, Ebrahiminezhad A, Manley-Harris M, Ghasemi Y, Berenjian A (2017) Iron oxide nanoparticles in modern microbiology and biotechnology. Crit Rev Microbiol 43(4):493–507. https://doi.org/10.1080/1040841X.2016.1267708
Duan X, Xiao J, Yin Q, Zhang Z, Yu H, Mao S, Li Y (2013) Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7:5858–5869
Durack E, Mallen S, O’Connor PM et al (2019) Protecting bactofencin A to enable its antimicrobial activity using mesoporous matrices. Int J Pharm 558(December2018):9–17. https://doi.org/10.1016/j.ijpharm.2018.12.035
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Younes M, Aggett P, Aguilar F, Crebelli R, Dusemund B, ... Lambré C (2018) Re‐evaluation of silicon dioxide (E 551) as a food additive. EFSA J 16(1):e05088
Encinas N, Angulo M, Astorga C, Colilla M, Izquierdo-Barba I, Vallet-Regí M (2019) Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties. Acta Biomater 84:317–327. https://doi.org/10.1016/j.actbio.2018.12.012
Fischbach MA, Walsh CT (2009) Antibiotics for emerging pathogens. Science 325:1089–1093
Flemming HC, Wingender J (2010) The biofilm matrix. Nat Rev Microbiol 8:623–633
Gao Y, Chen Y, Ji X, He X, Yin Q, Zhang Z, Shi J, Li Y (2011) Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS Nano 5:9788–9798
Gao F, Zhou H, Shen Z et al (2020) Synergistic antimicrobial activities of tea tree oil loaded on mesoporous silica encapsulated by polyethyleneimine. J Dispers Sci Technol 41(12):1859–1871. https://doi.org/10.1080/01932691.2019.1637755
Gao L, Li M, Ehrmann S, Tu Z, Haag R (2019) Positively charged nanoaggregates based on zwitterionic pillar [5] arene that combat planktonic bacteria and disrupt biofilms. Angew Chem Int Ed 58:3645−3649
Geilich BM, Gelfat I, Sridhar S, van de Ven AL, Webster TJ (2017) Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication. Biomaterials 119:78–85
Ghaseminezhad SM, Shojaosadati SA, Meyer RL (2018) Ag/ Fe3O4 nanocomposites penetrate and eradicate s. aureus biofilm in an in vitro chronic wound model. Colloids Surf B 163:192−200
Gimenez C, de la Torre C, Gorbe M, Aznar E, Sancenon F, Murguia JR, … Amoros P (2015) Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells. Langmuir 31(12):3753–3762. https://doi.org/10.1021/acs.langmuir.5b00139
Giri S, Trewyn BG, Stellmaker MP, Lin VS (2005) Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem (Int Ed Engl) 44(32):5038–5044. https://doi.org/10.1002/anie.200501819
Gisbert-Garzarán M, Manzano M, Vallet-Regí M (2020) Mesoporous silica nanoparticles for the treatment of complex bone diseases: bone cancer, bone infection and osteoporosis. Pharmaceutics 12:83. https://doi.org/10.3390/pharmaceutics12010083
Comments (0)